COVID-19 Drug Remdesivir's Price Must Not Cross Rs 1400: Maharashtra Health Minister Rajesh Tope
The Maharashtra government on Thursday decided to cap the price of Remdesivir between Rs 1,100 and Rs 1,400 per vial with Health Minister Rajesh Tope calling for slashing the MRP of the key COVID-19 drug.
He made it clear that the price of a Remdesivir injection should not cross Rs 1,400.
Mr Tope said with a rapid rise in COVID-19 cases, the state may need 1.5 lakh Remdesivir injections daily which would require ramping up of production.
The MRP of the anti-viral drug, widely used in treatment of serious coronavirus patients, runs into a few thousands.
Mr Tope said the COVID-19 drug should be available at a rate anywhere between Rs 1,100 and Rs 1,400.
Besides, he warned of a crackdown against stockists hoarding the medicine and asked doctors to be judicious in use of the injection.
He said Remdesivir manufacturers should supply the stock directly to government hospitals.
The stock sent to district collectors will be given to private hospitals as such a system will help to stop black-marketing and hoarding, Mr Tope said.